When does semaglutide’s patent expire in China?
The exact expiration date for semaglutide in China depends on which specific patent(s) cover the drug in practice (active ingredient, formulation, dosage regimen, manufacturing process, or related medical uses). The provided information does not include China-specific patent numbers or listed expiry dates, so a definitive “the patent expires on X date” answer can’t be verified here.
Is it about the active-ingredient patent or the Ozempic/Wegovy product patents?
In many countries, different patent “layers” can control exclusivity at different times. For semaglutide in China, generic or biosimilar entry timelines typically depend on which patents remain in force, such as:
- patents on the molecule (active ingredient),
- patents on specific formulations (e.g., injectable presentation),
- patents on dosing schedules or medical use claims,
- patents on manufacturing processes.
Without the China-specific patent list tied to semaglutide in your target product (Ozempic vs Wegovy), the controlling expiration can’t be determined from the question alone.
Can generics enter immediately after the main patent expires?
Even after a key patent expires, entry may still be delayed by other protections (additional patents still in force) or regulatory requirements (for example, requirements around approval for a particular indication and product form). China’s practical launch timing often tracks the last-expiring relevant patent rather than a single “main” one—again requiring the actual China patent set to calculate.
How do China patent terms work in general for drugs?
Drug-related patents in China generally follow patent law term rules (and any valid extensions, where applicable). Exact timing still requires the filing/priority dates and the specific patent documents covering semaglutide in China, because different patents can expire in different years.
What to search to find the exact expiry date for semaglutide in China
To pin down the real expiration date, you’d typically look up the China patents for:
- “semaglutide” (and Chinese transliterations),
- the brand or product name used in China (e.g., Ozempic or Wegovy),
- the patent holder(s) and assignee(s),
- the publication numbers and their grant/term details in CNIPA databases (or paid patent databases that mirror them).
If you share a patent number or product, I can narrow it to a specific expiry
If you tell me either (a) which product you mean (Ozempic or Wegovy/another semaglutide brand in China) and/or (b) a China patent number/publication number (CN… / CN-… / WO… linked family), I can help map which patent would control and what expiry date follows from that record.
Sources
No sources were provided with the prompt, so no citations are included.